Sunshine Guojian is one of the first bio-pharmaceutical companies in China to enter the international market. We have actively cooperated with local agents in countries in the Middle East, CIS, Latin America and Asia to expand our international business.
At present, the company has passed the on-site GMP inspection by drug regulatory authorities in many countries, including Colombia, Brazil (ICH member country), Ukraine, Indonesia, Mexico, Turkey (4 PIC/S member countries). At the same time, the company’s core products have been approved to be on the market by more than 15 overseas countries, and have been registering in more than 20 countries.
As many countries stepped up efforts to protect local manufacturers and imposed stricter requirements on drug administration, the company has adapted to the strategic requirements of internationalization by actively carrying out local production in core regional markets and taking the opportunity to create local joint venture projects. It is striving to become a world-leading Chinese antibody drug company.